METROPOLITAN LIFE INSURANCE CO/NY - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 1 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$488,398
+106.2%
14,1770.0%0.01%
+125.0%
Q2 2020$236,898
+15.9%
14,1770.0%0.00%0.0%
Q1 2020$204,432
-57.5%
14,177
-1.3%
0.00%
-50.0%
Q4 2019$480,930
+59.8%
14,3690.0%0.01%
+60.0%
Q3 2019$300,887
+0.6%
14,3690.0%0.01%0.0%
Q2 2019$299,163
-6.8%
14,3690.0%0.01%
-16.7%
Q1 2019$321,147
-6.6%
14,3690.0%0.01%
-14.3%
Q4 2018$343,706
-12.3%
14,3690.0%0.01%0.0%
Q3 2018$391,986
-99.9%
14,3690.0%0.01%
+16.7%
Q2 2018$386,383,000
+2.3%
14,369
+21.1%
0.01%
+20.0%
Q1 2018$377,758,000
+85754.1%
11,868
+2.1%
0.01%
-16.7%
Q4 2017$440,000
-28.3%
11,627
-53.1%
0.01%
+50.0%
Q3 2017$614,000
+20.6%
24,7730.0%0.00%0.0%
Q2 2017$509,000
+20.6%
24,773
+27.7%
0.00%
+33.3%
Q1 2017$422,000
-0.7%
19,401
-6.7%
0.00%0.0%
Q4 2016$425,000
+36.2%
20,7960.0%0.00%
+50.0%
Q3 2016$312,000
+38.7%
20,7960.0%0.00%0.0%
Q2 2016$225,000
+73.1%
20,796
+116.2%
0.00%
+100.0%
Q1 2016$130,000
-20.2%
9,617
+9.0%
0.00%0.0%
Q4 2015$163,0008,8200.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 3,100,146$117,248,00040.96%
TLP GROUP LLC 1,050,000$39,711,00027.53%
Aisling Capital LLC 2,240,000$84,717,00016.74%
Foresite Capital Management III, LLC 764,824$28,926,0008.12%
AlpInvest Partners B.V. 51,498$1,948,0006.95%
Vivo Capital, LLC 643,626$24,342,0005.21%
GREAT POINT PARTNERS LLC 573,550$21,692,0003.70%
Eventide Asset Management 1,226,000$46,367,0002.42%
Palo Alto Investors LP 1,146,419$43,358,0001.87%
HAMILTON LANE ADVISORS LLC 78,846$2,982,0001.54%
View complete list of AIMMUNE THERAPEUTICS INC shareholders